Delivery Order SPE2DB20D3303-SPE2DB25FA3HF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Fulphila 6 mg/0.6 ml syringes valued at $6,205.73, with completion expected by July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery under AmerisourceBergen's larger federal...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 22, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply FULPHILA 6 mg/0.6 mL syringes with a contract value of $10,523.70. The delivery order is structured as a firm fixed price contract with no set-aside designation, indicating it was competitively awarded. Performance of this delivery order will be completed by July 23, 2025, at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fulphila 6 mg/0.6 mL syringes. The $11,674.80 firm fixed-price delivery order has a completion date of November 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a range of pharmaceutical products and medical supplies to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML. The contract has a ceiling value of $21,453.34 and runs through April 8, 2025. It is a firm fixed price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- The Defense Logistics Agency awarded a $30,149.93 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561696863 FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The delivery order, which runs from August 3 to August 4, 2023, was issued under an existing indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of the Department of Defense's medical...
- This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6DUC, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,280.00 delivery order contract is for the supply of FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML, a medical product, with a completion date of November 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $2,937.60 firm fixed price delivery order by the Defense Logistics Agency to supply 4561772794 FULPHILA 6 MG/0.6 ML SYRINGES in quantities of 0.6mL each. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between August 10-11, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations, suggesting...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product FULPHILA 6 MG/0.6 ML SYRINGE 0.6ML. The contract has a ceiling value of $12,452.29 and is a firm fixed-price delivery order type contract with an ultimate completion date of December 27, 2023. The contract is not set aside and was awarded on December 26, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fulvestrant 250 mg/5 mL syringes with a ceiling value of $1,145.70. This non-set-aside, competitively awarded delivery order features firm fixed pricing and is scheduled for completion by August 8, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Department of Defense's Medical Supply Chain awarded a $1,530.00 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Fulvestrant 250 mg/5 mL syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single delivery order fulfillment under AmerisourceBergen's larger indefinite delivery contract...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3HFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,314.82 to AmerisourceBergen Drug Corp for Fulphila 6 mg/0.6 mL syringes on September 4, 2025, with completion scheduled for September 5, 2025. This delivery order operates under a firm fixed price structure with no set-aside designation, indicating open competitive award. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical pharmaceutical distributor for federal medical procurement needs. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through competitive awards, combined with its extensive portfolio of specialty medications and medical devices across multiple therapeutic domains, positions the company as a key vendor within the DLA's medical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 9/4/25 |